Lucira Health (LHDX) Stock Soared 15.21% At Premarket Trading. Here’s What Happened

Lucira Health, Inc. (LHDX), a biotechnology company specializing in the production and expansion of lucrative infectious disease test kits, notified it can efficiently distinguish the “double mutant” variant of COVID-19 with its molecular test kit. LHDX stock price saw a 15.21% gain following the news. The “double mutant” variant was initially found in India on […]